Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
James Januzzi, MD
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Akshay S. Desai, MD
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Marc Bonaca, MD
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Erik Stroes, MD, PhD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.